Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
In the final weeks of 2018, the U.S. Food and Drug Administration (FDA) announced three approvals of anticancer therapeutics....
January is Cervical Cancer Awareness Month. Given that January was named after the Roman god Janus, whose two faces...
In addition to world-class training in patient care, physician-scientists also require experience in laboratory and clinic-based research to ensure...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
The staff of Cancer Research Catalyst was pleased to introduce a new feature this year: Editors' Picks, a monthly...
On September 6, 2018, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research hosted...
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
The past two weeks have seen a flurry of U.S. Food and Drug Administration (FDA) approvals of new treatments...
Radiotherapy is a mainstay of cancer treatment. In recent years, improved technology has allowed many cancer patients to receive...